echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Sub-Journal: "Alzheimer's Disease" is about to be renamed?

    JAMA Sub-Journal: "Alzheimer's Disease" is about to be renamed?

    • Last Update: 2021-07-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    September 21, 2020 is the 27th World Alzheimer's Day, that is, "World Dementia Day".


    According to data from Alzheimer's Disease International, the disease affects 50 million people worldwide, with an average of new cases of dementia appearing every 3 seconds


    It is estimated that the number of patients will reach 25% of the population in 2030


    The diagnosis and treatment of progressive cognitive dysfunction in young people is different from that of older adults


    Diagnosis However, the most common causes of early-onset dementia in young adults and older adults are the same, including: Alzheimer's disease (AD), vascular dementia (VD), and frontotemporal dementia (FTD)


    Early-onset dementia refers to dementia that occurs in adults aged 18-65 years


    JAMA

    Researchers systematically searched the population-based studies on the prevalence of YOD published between January 1, 1990 and March 31, 2020 in PubMed, Embase, CINAHL, and PsycInfo databases


    This systematic review includes a total of 95 unique studies, of which 2,760,379 unique patients from 74 studies were also included in the 5-year-old meta-analysis


    The age-standardized estimated prevalence rate increased from 1.


    Therefore, the global age-standardized prevalence rate for the 30-64 age group is 119.


    The overall age-standardized prevalence rate for the 30 to 64-year-old age group worldwide is 119.


    Further analysis found that the prevalence rate in high-income countries (663.


    In addition, YOD may also be related to factors such as genetics (such as Huntington's disease), mitochondrial diseases, inflammatory diseases, infectious diseases, poisoning (the causes of poisoning are alcohol, drug abuse, and heavy metals), adrenal leukodystrophy, metabolic disorders and other factors


    In summary, the age-standardized prevalence rate of YOD is 1.


    In summary, the age-standardized prevalence rate of YOD is 1.


    references:

    Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis.


    Global Prevalence of Young-Onset Dementia: A Systematic Review and Meta-analysis.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.